US FDA Draft Guidance On Medical Device Animal Studies Is 'Confusing', Says Industry
This article was originally published in SRA
Executive Summary
The US Food and Drug Administration's recent draft guidance on how medical device companies should design and report the results of animal studies is 'confusing', says medtech industry association AdvaMed1,2.
You may also be interested in...
FDA's Updated Draft Animal Testing Guidance Clarifies Its Scope
The US FDA’s guidance document on animal testing for medical devices clarifies the scope of a document issued in 2016.
Global Pharma Guidance Tracker – March 2024
Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.
EU Regulators Explain How To Ensure Transitioned Trials Align With CTR
Members of the EU’s Clinical Trials Coordination Group have developed harmonized requirements for updating trials that are transitioned to the Clinical Trials Information System based on a minimum set of documents.